期刊论文详细信息
JOURNAL OF CONTROLLED RELEASE 卷:320
Nanostructured toxins for the selective destruction of drug-resistant human CXCR4+ colorectal cancer stem cells
Article
Serna, Naroa1,2,3  Alamo, Patricia3  Ramesh, Prashanthi6,7  Vinokurova, Daria6,7  Sanchez-Garcia, Laura1,2,3  Unzueta, Ugutz3,4,5  Gallardo, Alberto3,4,5  Virtudes Cespedes, Maria3,4,5  Vazquez, Esther1,2,3  Villaverde, Antonio1,2,3  Mangues, Ramon3,4,5  Medema, Jan Paul6,7 
[1] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain
[3] CIBER BBN, Barcelona 08193, Spain
[4] Hosp Santa Creu & Sant Pau, Biomed Res Inst St Pau IIB St Pau, Barcelona 08025, Spain
[5] Hosp Santa Creu & Sant Pau, Josep Carreras Res Inst, Barcelona 08025, Spain
[6] Univ Amsterdam, Amsterdam UMC, LEXOR, Ctr Expt & Mol Med,Canc Ctr Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[7] Oncode Inst, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
关键词: Protein nanoparticles;    Genetic engineering;    Self-assembling;    Drug delivery;    Cancer stem cells;    Cell signaling;   
DOI  :  10.1016/j.jconrel.2020.01.019
来源: Elsevier
PDF
【 摘 要 】

Current therapies fail to eradicate colorectal Cancer Stem Cells (CSCs). One of the proposed reasons for this failure is the selection, by chemotherapy exposure, of resistant cells responsible for tumor recurrence. In this regard, CXCR4 overexpression in tumor associates with resistance and poor prognosis in colorectal cancer (CRC) patients. In this study, the effectiveness of engineered CXCR4-targeted self-assembling toxin nanoparticles has been explored in the selective killing of CXCR4(+) human colon-CSCs compared to 5-Fluorouracil and Oxaliplatin, both classical CRC chemotherapeutic agents. To assess this, 3D spheroid colon-CSCs cultures directly derived from CRC patients and CRC-CSC spheroid-derived tumor mouse models were developed. In these animal models, nanostructured toxins show highly selective induction of pyroptosis in the absence of apoptosis, thus having a great potential to overcome tumor resistance, since the same tumor models show resistance to chemotherapeutics. Results set the basis for further development of more efficient therapies focused on selective CXCR4+ CSCs elimination activating non-apoptotic mechanisms and represent a pre-clinical proof of concept for the use of CSCs-targeted nanostructured toxins as protein drugs for CRC therapy.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_jconrel_2020_01_019.pdf 4017KB PDF download
  文献评价指标  
  下载次数:23次 浏览次数:0次